Literature DB >> 30380390

Application of Cell-free DNA Analysis to Cancer Treatment.

Ryan B Corcoran1, Bruce A Chabner1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30380390     DOI： 10.1056/NEJMra1706174

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  178 in total

1.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.

Authors:  Mark A Applebaum; Erin K Barr; Jason Karpus; Diana C West-Szymanski; Meritxell Oliva; Elizabeth A Sokol; Sheng Zhang; Zhou Zhang; Wei Zhang; Alexandre Chlenski; Helen R Salwen; Emma Wilkinson; Marija Dobratic; Robert L Grossman; Lucy A Godley; Barbara E Stranger; Chuan He; Susan L Cohn
Journal:  Clin Cancer Res       Date:  2019-12-18       Impact factor: 12.531

Review 3.  Clinical validity of saliva and novel technology for cancer detection.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Fang Wei; Shannon Liu Rao; Jinseok Kim; Heebum Shin; Jordan Cheng; Michael Tu; David T W Wong; Yong Kim
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

4.  Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.

Authors:  Michael P Douglas; Stacy W Gray; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2020-07       Impact factor: 11.908

Review 5.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 6.  The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.

Authors:  Rachel Hu; Allison Winter; Brian T Hill
Journal:  Curr Oncol Rep       Date:  2019-04-02       Impact factor: 5.075

7.  Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.

Authors:  Jan Trøst Jørgensen
Journal:  Oncologist       Date:  2019-04-02

8.  Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma.

Authors:  Takuma Nakatsuka; Hayato Nakagawa; Yuki Hayata; Taijiro Wake; Tomoharu Yamada; Mizuki Nishibatake Kinoshita; Ryo Nakagomi; Masaya Sato; Tatsuya Minami; Koji Uchino; Kenichiro Enooku; Yotaro Kudo; Yasuo Tanaka; Takahiro Kishikawa; Motoyuki Otsuka; Ryosuke Tateishi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-03-12       Impact factor: 7.527

Review 9.  Next generation sequencing in gastric or gastroesophageal adenocarcinoma.

Authors:  Geoffrey Y Ku
Journal:  Transl Gastroenterol Hepatol       Date:  2020-10-05

Review 10.  Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Authors:  Feifei Bi; Qiwei Wang; Qian Dong; Yuanhe Wang; Liqun Zhang; Jingdong Zhang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.